Our above observations indicate that survivin expression in the tumor-specific CTLs is not only differentially induced by tumor cells and CD3 mAb stimulation (Fig. 7A) but also correlated with STAT1 activation (Fig. 7C), suggesting that survivin might also be a target gene of the IFN-γ signaling pathway. The gene discussed is BIRC5; the disease is neoplasm.